Found 5 matching trials
A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)
PHASE1This study will evaluate thrice weekly dosing with vintafolide to find the ...
Location
Multiple Locations
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
PHASE3The purpose of this study is to compare progression-free survival (PFS) (ba...
Location
Multiple Locations
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
PHASE2The objective of this study is to compare progression-free survival (PFS), ...
Location
Multiple Locations
Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010)
PHASE2This extension protocol is for those subjects that have completed the allow...
Location
Center for Blood and Cancer Disorders
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)
PHASE1This is a Phase I clinical trial evaluating the safety and tolerability of ...
Location
Greenebaum Cancer Center at University of Maryland Medical Center